Physician profile
Christopher Oermann
NPI 1821178237
$2,600.05
in general payments reported to CMS, 2019-2025
18 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,228 · 2020: $126 · 2021: $257 · 2022: $397 · 2023: $129 · 2024: $258 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.58 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $987.10 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $343.53 | 2019-2025 | Trikafta |
| Regeneron Healthcare Solutions, INC. | $183.26 | 2019-2024 | Dupixent |
| Mylan Specialty L.P. | $169.06 | 2020-2022 | |
| Genentech USA, INC. | $152.00 | 2019-2023 | Xolair |
| Abbvie INC. | $135.11 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $130.38 | 2019-2024 | |
| Chiesi USA, INC. | $94.14 | 2019-2021 | |
| Insmed, INC. | $71.08 | 2025 | Arikayce |
| Vivus LLC | $60.93 | 2022-2024 | Pancreaze |
| Aimmune Therapeutics, INC. | $58.84 | 2024-2025 | Zenpep |
| Baxter Healthcare | $52.29 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Nestle Healthcare Nutrition INC. | $49.26 | 2022-2023 | |
| Jazz Pharmaceuticals INC. | $34.24 | 2019-2020 | |
| Amgen INC. | $23.03 | 2024 | Tezspire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Digestive Care, INC. | $22.16 | 2025 | Pertzye |
| Allergan, INC. | $19.64 | 2020 | |
| Electromed, INC. | $14.00 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Oermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.